HC-011

N/A

Report date: 2023/03/31 17:22:51

Base Information

Drug NameHC-011
Drug Alias NameHC-011HC011
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Haichang Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Haichang Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A